• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AROA BIOSURGERY LTD. OVITEX REINFORCED TISSUE MATRIX; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AROA BIOSURGERY LTD. OVITEX REINFORCED TISSUE MATRIX; SURGICAL MESH Back to Search Results
Model Number F10246-1012P
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abscess (1690); Seroma (2069)
Date of Event 11/28/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the batch record showed no nonconformances or other anomalies that may have caused or contributed to the event reported.Testing was completed on similar units which showed the device met the tested specification.
 
Event or Problem Description
A patient with perforated diverticulitis post colostomy underwent robotic lysis of adhesions, partial colectomy and low colorectal anastomosis to take down the colostomy.The surgeon then made an exterior incision at site of the colostomy to close the defect.The surgeon placed ovitex in an onlay fashion over the closed defect.During post-surgical follow up the patient experienced an abscess and persistent seroma which has been drained multiple times under interventional radiology.
 
Event or Problem Description
A patient with perforated diverticulitis post colostomy underwent robotic lysis of adhesions, partial colectomy and low colorectal anastomosis to take down the colostomy.The surgeon then made an exterior incision at site of the colostomy to close the defect.The surgeon placed ovitex in an onlay fashion over the closed defect.During post-surgical follow up the patient experienced an abscess and persistent seroma which has been drained multiple times under interventional radiology.
 
Additional Manufacturer Narrative
A review of the batch record showed no nonconformances or other anomalies that may have caused or contributed to the event reported.Testing was completed on similar units which showed the device met the tested specification.Note: submission of this report through esg was delayed due to ongoing issues with access to the webtrader application.Multiple tickets lodged with the esg help desk are on file at aroa biosurgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVITEX REINFORCED TISSUE MATRIX
Common Device Name
SURGICAL MESH
Manufacturer (Section D)
AROA BIOSURGERY LTD.
2 kingsford smith place
airport oaks, auckland 2022
NZ  2022
Manufacturer (Section G)
AROA BIOSURGERY LTD.
2 kingsford smith place
airport oaks, auckland 2022
NZ   2022
Manufacturer Contact
tina o'brien
2 kingsford smith place
airport oaks, auckland 2022
NZ   2022
MDR Report Key16143272
Report Number3007321028-2022-00055
Device Sequence Number6736526
Product Code FTM
UDI-Device Identifier09421904065093
UDI-Public09421904065093
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K153632
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date10/31/2024
Device Model NumberF10246-1012P
Device Catalogue NumberF10246-1012P
Device Lot NumberERT-21K06
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/08/2022
Supplement Date Received by Manufacturer12/08/2022
Initial Report FDA Received Date01/11/2023
Supplement Report FDA Received Date01/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured11/08/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
IODOFORM GAUZE; IODOFORM GAUZE
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient Age55 YR
Patient SexFemale
Patient Weight88 KG
-
-